Acute Lymphocytic Leukemia Market to Reach US$ 5.3 Billion by 2034 at 6.05% CAGR
Acute lymphocytic leukemia is one of the most common blood cancers, particularly affecting children while also occurring in adults. Continuous advances in treatment strategies and improved diagnostic technologies are reshaping the global treatment landscape. Growing awareness, earlier diagnosis, and the …